Literature DB >> 11108158

Drug delivery by the intravaginal route.

A D Woolfson1, R K Malcolm, R Gallagher.   

Abstract

The human vagina represents a potential, accessible space that offers a valuable route for drug delivery through the use of specifically designed carrier systems for both local and systemic applications. Intravaginal drug delivery is particularly appropriate for drugs associated with women's health issues but may also have applications in general drug delivery within the female population. A range of drug delivery platforms suitable for intravaginal administration are discussed in this review, including hydrogels, vaginal tablets, pessaries/suppositories, particulate systems, and intravaginal rings. Drug release mechanisms and absorption pathways are reviewed with respect to a range of therapeutic and prophylactic indications for intravaginal delivery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108158

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  23 in total

1.  Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.

Authors:  Martha Stefanidou; Carolina Herrera; Naomi Armanasco; Robin J Shattock
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

4.  Advances in vaginal drug delivery.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

5.  Accidental death via intravaginal absorption of methamphetamine.

Authors:  Prentiss Jones; Romeo Mutsvunguma; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-02-11       Impact factor: 2.007

6.  Sustained release of proteins from a modified vaginal ring device.

Authors:  Ryan J Morrow; A David Woolfson; Louise Donnelly; Rhonda Curran; Gavin Andrews; Dietmar Katinger; R Karl Malcolm
Journal:  Eur J Pharm Biopharm       Date:  2010-11-03       Impact factor: 5.571

7.  Development of a UC781 releasing polyethylene vinyl acetate vaginal ring.

Authors:  Christopher McConville; Ian Major; David R Friend; Meredith R Clark; R Karl Malcolm
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

8.  Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.

Authors:  Muneeb Mohideen; Elias Quijano; Eric Song; Yang Deng; Gauri Panse; Wei Zhang; Meredith R Clark; W Mark Saltzman
Journal:  Biomaterials       Date:  2017-08-15       Impact factor: 12.479

9.  The involvement of intracellular calcium in the MCT-mediated uptake of lactic acid by HeLa cells.

Authors:  Sravanthi Cheeti; Chi H Lee
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 10.  The vagina as a route for drug delivery: a review.

Authors:  Sushma Srikrishna; Linda Cardozo
Journal:  Int Urogynecol J       Date:  2012-12-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.